April 11 (Reuters) - Manitex Capital Inc MNX.V :
* Manitex Capital Inc's affiliate, Valeo (PA:VLOF) Pharma Inc, announces partnership for a parkinson's disease treatment
* Manitex Capital- entered into partnership with Zambon s.p.a. For exclusive Canadian rights to commercialize new parkinson's disease product Xadago
* Manitex Capital Inc says valeo pharma will pay zambon upfront, regulatory and commercial milestone payments as well as royalties on product sales
* Manitex Capital - under terms of deal, Valeo Pharma to be responsible for all regulatory, sales, marketing, quality, distribution activities in Canada
* Manitex Capital - agreement grants Valeo Pharma exclusive rights to commercialise Zambon's parkinson's disease product, licensed from Newron Source text for Eikon: ID:nCNWnHQn3a Further company coverage: MNX.V